InvestorsHub Logo
Followers 840
Posts 120470
Boards Moderated 18
Alias Born 09/05/2002

Re: north40000 post# 2710

Friday, 12/01/2017 11:41:27 AM

Friday, December 01, 2017 11:41:27 AM

Post# of 4875
ABBV/ENTA's Mavyret will eventually be approved in China, at which time GILD's market share will drop. But I agree with the author that China will become a large market for HCV drugs.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News